PP2D1
gene geneOn this page
Also known as FLJ25449
Summary
PP2D1 (protein phosphatase 2C like domain containing 1, HGNC:28406) is a protein-coding gene on chromosome 3p24.3, encoding Protein phosphatase 2C-like domain-containing protein 1 (A8MPX8).
Predicted to enable protein serine/threonine phosphatase activity. Predicted to be involved in negative regulation of MAPK cascade and signal transduction. Predicted to be active in cytoplasm and nucleus.
Source: NCBI Gene 151649 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 7 total
- MANE Select transcript:
NM_001252657
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28406 |
| Approved symbol | PP2D1 |
| Name | protein phosphatase 2C like domain containing 1 |
| Location | 3p24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25449 |
| Ensembl gene | ENSG00000183977 |
| Ensembl biotype | protein_coding |
| OMIM | 621037 |
| Entrez | 151649 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 1 nonsense_mediated_decay, 1 protein_coding, 1 retained_intron
ENST00000333083, ENST00000389050, ENST00000461033
RefSeq mRNA: 1 — MANE Select: NM_001252657
NM_001252657
CCDS: CCDS58817
Canonical transcript exons
ENST00000389050 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001317787 | 20001030 | 20002096 |
| ENSE00001504765 | 19985346 | 19986182 |
| ENSE00001860873 | 20012050 | 20012264 |
Expression profiles
Bgee: expression breadth ubiquitous, 158 present calls, max score 91.34.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0320 / max 29.7716, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 41415 | 0.0161 | 3 |
| 41413 | 0.0079 | 3 |
| 41414 | 0.0079 | 3 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 91.34 | gold quality |
| left testis | UBERON:0004533 | 81.62 | gold quality |
| right testis | UBERON:0004534 | 80.78 | gold quality |
| testis | UBERON:0000473 | 79.79 | gold quality |
| buccal mucosa cell | CL:0002336 | 69.34 | silver quality |
| monocyte | CL:0000576 | 67.77 | gold quality |
| leukocyte | CL:0000738 | 66.07 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 62.73 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 62.03 | gold quality |
| islet of Langerhans | UBERON:0000006 | 60.89 | gold quality |
| bone marrow cell | CL:0002092 | 59.65 | gold quality |
| right lung | UBERON:0002167 | 59.20 | gold quality |
| mucosa of stomach | UBERON:0001199 | 58.79 | gold quality |
| tendon | UBERON:0000043 | 58.46 | silver quality |
| skin of abdomen | UBERON:0001416 | 58.11 | gold quality |
| left uterine tube | UBERON:0001303 | 57.98 | gold quality |
| skin of leg | UBERON:0001511 | 57.94 | gold quality |
| rectum | UBERON:0001052 | 57.83 | gold quality |
| stromal cell of endometrium | CL:0002255 | 57.68 | gold quality |
| ectocervix | UBERON:0012249 | 57.46 | gold quality |
| pancreas | UBERON:0001264 | 57.21 | gold quality |
| tibial artery | UBERON:0007610 | 57.00 | gold quality |
| popliteal artery | UBERON:0002250 | 56.97 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 56.72 | gold quality |
| aorta | UBERON:0000947 | 56.71 | gold quality |
| ascending aorta | UBERON:0001496 | 56.67 | gold quality |
| thoracic aorta | UBERON:0001515 | 56.60 | gold quality |
| body of pancreas | UBERON:0001150 | 56.50 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 56.46 | gold quality |
| upper lobe of lung | UBERON:0008948 | 56.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.01 |
Regulation
Is transcription factor: no
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pp2d1 | ENSMUSG00000044957 |
| rattus_norvegicus | Pp2d1 | ENSRNOG00000004719 |
| drosophila_melanogaster | Pdp | FBGN0029958 |
| drosophila_melanogaster | CG10376 | FBGN0032702 |
| drosophila_melanogaster | Ppm1 | FBGN0035143 |
| drosophila_melanogaster | CG17746 | FBGN0035425 |
| drosophila_melanogaster | Nil | FBGN0039421 |
| drosophila_melanogaster | alph | FBGN0086361 |
| caenorhabditis_elegans | WBGENE00006460 | |
| caenorhabditis_elegans | WBGENE00018362 | |
| caenorhabditis_elegans | pdp-1 | WBGENE00022832 |
Paralogs (16): PPM1F (ENSG00000100034), TAB1 (ENSG00000100324), PPM1A (ENSG00000100614), PPM1H (ENSG00000111110), PPM1G (ENSG00000115241), ILKAP (ENSG00000132323), PPM1B (ENSG00000138032), PPM1J (ENSG00000155367), PPM1L (ENSG00000163590), PPM1K (ENSG00000163644), PPM1M (ENSG00000164088), PDP1 (ENSG00000164951), PPM1D (ENSG00000170836), PDP2 (ENSG00000172840), PPM1E (ENSG00000175175), PPM1N (ENSG00000213889)
Protein
Protein identifiers
Protein phosphatase 2C-like domain-containing protein 1 — A8MPX8 (reviewed: A8MPX8)
All UniProt accessions (1): A8MPX8
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the PP2C family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A8MPX8-1 | 1 | yes |
| A8MPX8-2 | 2 | |
| A8MPX8-3 | 3 |
RefSeq proteins (1): NP_001239586* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001932 | PPM-type_phosphatase-like_dom | Domain |
| IPR015655 | PP2C | Family |
| IPR036457 | PPM-type-like_dom_sf | Homologous_superfamily |
Pfam: PF00481
UniProt features (11 total): splice variant 4, sequence variant 3, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MPX8-F1 | 71.02 | 0.40 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY, GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY, chr3p24, GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY, GOMF_PHOSPHATASE_ACTIVITY, SMTTTTGT_UNKNOWN, DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS, GOBP_MAPK_CASCADE, GOBP_NEGATIVE_REGULATION_OF_CELL_COMMUNICATION, GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP, GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS
GO Biological Process (3): signal transduction (GO:0007165), negative regulation of MAPK cascade (GO:0043409), protein dephosphorylation (GO:0006470)
GO Molecular Function (1): protein serine/threonine phosphatase activity (GO:0004722)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| MAPK cascade | 1 |
| regulation of MAPK cascade | 1 |
| negative regulation of intracellular signal transduction | 1 |
| dephosphorylation | 1 |
| protein modification process | 1 |
| phosphoprotein phosphatase activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
957 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PP2D1 | SPINT4 | Q6UDR6 | 507 |
| PP2D1 | PPTC7 | Q8NI37 | 475 |
| PP2D1 | HCFC1R1 | Q9NWW0 | 458 |
| PP2D1 | SAXO1 | Q8IYX7 | 456 |
| PP2D1 | D6RAR5 | D6RAR5 | 411 |
| PP2D1 | PPM1M | Q96MI6 | 392 |
| PP2D1 | PPM1J | Q5JR12 | 390 |
| PP2D1 | SIAH3 | Q8IW03 | 388 |
| PP2D1 | ZMYM5 | Q9UJ78 | 379 |
| PP2D1 | ABHD17B | Q5VST6 | 371 |
| PP2D1 | LSM5 | Q9Y4Y9 | 360 |
| PP2D1 | PPP1R1C | Q8WVI7 | 348 |
| PP2D1 | ALKBH7 | Q9BT30 | 339 |
| PP2D1 | TRIM67 | Q6ZTA4 | 331 |
| PP2D1 | NUDT11 | Q96G61 | 328 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PP2D1 | iglC2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| M | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): PP2D1 (Reconstituted Complex), PP2D1 (Synthetic Lethality), APP (Reconstituted Complex)
ESM2 similar proteins: A0JMR6, A2RRS8, A6NFN9, A8MPX8, B1ANS9, O15297, O75747, P25022, P79457, Q08AW4, Q14680, Q14AW5, Q15052, Q2IBB1, Q2IBB4, Q2IBG0, Q2QL84, Q2QLH1, Q3MJ13, Q3US16, Q4R3G4, Q4R7Q1, Q5H913, Q5JTW2, Q5R5T0, Q5R6E1, Q5RFQ4, Q5SUS0, Q5XGI3, Q5XX13, Q5XXR3, Q692V3, Q6P2S7, Q6P3V7, Q7XVF9, Q86VS3, Q8BVT6, Q8C0W1, Q8C5W4, Q8IV35
Diamond homologs: A5PJZ2, A6K136, A8MPX8, O04719, O60346, O64583, P40371, P49595, P49597, P49598, Q0D673, Q0JAA0, Q2PC20, Q2QWE3, Q4PSE8, Q53Q11, Q5R522, Q5SGD2, Q65XK7, Q6EN45, Q6L4R7, Q6L5C4, Q6L5H6, Q6ZVD8, Q7XQU7, Q7XR06, Q8BVT6, Q8BXN7, Q8CHE4, Q8LAY8, Q8N3J5, Q93YW5, Q9FIF5, Q9LDA7, Q9LME4, Q9LNW3, Q9S9Z7, Q9WTR8, Q9XEE8, Q9ZW21
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
740 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:19983702:TTTCA:T | acceptor_loss | 0.9900 |
| 3:19983703:TTCAG:T | acceptor_loss | 0.9900 |
| 3:19983704:TCAG:T | acceptor_loss | 0.9900 |
| 3:19983705:CA:C | acceptor_loss | 0.9900 |
| 3:19983706:A:AG | acceptor_gain | 0.9900 |
| 3:19983706:AGCT:A | acceptor_loss | 0.9900 |
| 3:19983707:G:GG | acceptor_gain | 0.9900 |
| 3:19983707:GCT:G | acceptor_gain | 0.9900 |
| 3:19983707:GCTA:G | acceptor_gain | 0.9900 |
| 3:19983707:GCTAA:G | acceptor_gain | 0.9900 |
| 3:20001498:C:CT | acceptor_gain | 0.9900 |
| 3:20002095:CT:C | acceptor_gain | 0.9900 |
| 3:19980095:G:T | donor_gain | 0.9800 |
| 3:20001495:C:CT | acceptor_gain | 0.9800 |
| 3:20001507:C:CT | acceptor_gain | 0.9800 |
| 3:20002093:CACT:C | acceptor_gain | 0.9800 |
| 3:19983707:GC:G | acceptor_gain | 0.9700 |
| 3:20001486:CGTGA:C | acceptor_gain | 0.9700 |
| 3:20008055:G:C | donor_gain | 0.9700 |
| 3:20001508:A:T | acceptor_gain | 0.9600 |
| 3:20008132:CG:C | donor_gain | 0.9600 |
| 3:19986180:TACCT:T | acceptor_loss | 0.9500 |
| 3:19986181:ACC:A | acceptor_loss | 0.9500 |
| 3:19986182:CCTAA:C | acceptor_loss | 0.9500 |
| 3:19986183:C:CG | acceptor_loss | 0.9500 |
| 3:19986184:T:G | acceptor_loss | 0.9500 |
| 3:20001499:A:T | acceptor_gain | 0.9500 |
| 3:20001937:C:A | donor_gain | 0.9500 |
| 3:19982668:G:GG | donor_gain | 0.9400 |
| 3:20008045:A:AC | donor_gain | 0.9400 |
AlphaMissense
4174 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:20001039:C:G | A361P | 0.980 |
| 3:19985901:A:G | W458R | 0.977 |
| 3:19985901:A:T | W458R | 0.977 |
| 3:20001171:A:G | C317R | 0.974 |
| 3:20001038:G:T | A361E | 0.972 |
| 3:19985924:A:G | L450P | 0.971 |
| 3:19985927:A:G | F449S | 0.971 |
| 3:19986164:A:G | L370S | 0.971 |
| 3:19985459:G:T | A605D | 0.970 |
| 3:19985471:A:G | L601P | 0.970 |
| 3:19985492:G:T | A594D | 0.970 |
| 3:19985951:A:T | V441D | 0.970 |
| 3:19985899:C:A | W458C | 0.968 |
| 3:19985899:C:G | W458C | 0.968 |
| 3:20001047:A:G | L358S | 0.968 |
| 3:19985479:G:C | S598R | 0.967 |
| 3:19985479:G:T | S598R | 0.967 |
| 3:19985481:T:G | S598R | 0.967 |
| 3:19985934:A:G | C447R | 0.966 |
| 3:19985426:A:T | V616D | 0.964 |
| 3:20001250:A:C | F290L | 0.964 |
| 3:20001250:A:T | F290L | 0.964 |
| 3:20001252:A:G | F290L | 0.964 |
| 3:20001255:C:G | A289P | 0.962 |
| 3:19985471:A:T | L601H | 0.961 |
| 3:20001041:A:T | V360D | 0.959 |
| 3:19985916:C:G | A453P | 0.958 |
| 3:20001452:A:G | L223P | 0.957 |
| 3:20001195:A:G | W309R | 0.956 |
| 3:20001195:A:T | W309R | 0.956 |
dbSNP variants (sampled 300 via entrez): RS1000106887 (3:19997518 C>G), RS1000352050 (3:20010941 G>A), RS1000403071 (3:20002265 G>T), RS1000465847 (3:19986828 C>A,G,T), RS1000544918 (3:19995867 A>G), RS1000547223 (3:19995598 G>A), RS1000842221 (3:20005638 T>C), RS1001056060 (3:19992689 A>G), RS1001112039 (3:19999153 C>T), RS1001247610 (3:20006676 G>A), RS1001256803 (3:20013300 C>A,G,T), RS1001309721 (3:20009951 A>C,G), RS1001336915 (3:20005366 C>T), RS1001347684 (3:20003933 A>C), RS1001383197 (3:19996671 G>C)
Disease associations
OMIM: gene MIM:621037 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003181_1 | Staphylococcus aureus nasal carriage (intermittent) | 9.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007758 | intermittent Staphylococcus aureus carrier status |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| Lipopolysaccharides | increases expression, affects response to substance | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.